A hormone combination improves strength and function in FSHD patients

New research has demonstrated that a combined regimen of growth hormone and testosterone is safe, well-tolerated, and is associated with meaningful improvements in muscle mass, strength, and mobility for men living with facioscapulohumeral muscular dystrophy (FSHD). Researchers believe that this regimen could benefit patients with other forms of muscular dystrophy.

👉 Full Story